The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans

(2011) M. A. Nauck et al.   DIABETES

Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes

(2011) J. Ma et al.   DIABETIC MEDICINE

Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice

(2011) Aurélie Waget et al.   ENDOCRINOLOGY

Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as “Isoglycemic” Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes

(2011) Irfan Vardarli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

(2010) M. Salehi et al.   DIABETES

Endogenous GLP-1 Regulates Postprandial Glycemia in Humans: Relative Contributions of Insulin, Glucagon, and Gastric Emptying

(2010) Mathias Nicolaus et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis

(2010) T. Edholm et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion

(2010) Anne-Barbara Witte et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia

(2009) Adam M. Deane et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors

(2009) E.J. Verspohl   PHARMACOLOGY & THERAPEUTICS

Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man

(2009) A.-B. Witte et al.   REGULATORY PEPTIDES

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

(2008) Daniel J Drucker et al.   LANCET

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

(2008) Helle Linnebjerg et al.   REGULATORY PEPTIDES